Table 1.
BD-I | BD-II | BD-NOS | p-value (F or χ²) | |
---|---|---|---|---|
Sample size | 45 | 13 | 13 | |
Age (mean (SD)) | 52.60 (15.06) | 51.46 (15.22) | 51.54 (11.25) | n.s |
Length of first hospitalization (median [IQR]) | 15.00 [8.00, 22.00] | 14.00 [7.00, 17.00] | 10.00 [6.00, 15.00] | n.s. |
Gender (N (Female %)) | 23 (51.1) | 8 (61.5) | 9 (69.2) | |
Mood stabilizer at first discharge (%) | ||||
No. | 15 (33.3) | 5 (38.5) | 5 (38.5) | n.s. |
Yes | 30 (66.7) | 8 (61.5) | 8 (61.5) | |
No. of comorbidities (median [IQR]) | 1.00 [0.00, 2.00] | 1.00 [0.00, 2.00] | 0.00 [0.00, 2.00] | n.s. |
No. of medications prescribed (median [IQR]) | 3.00 [2.00, 5.00] | 3.00 [3.00, 4.00] | 3.00 [2.00, 4.00] | n.s. |
Age at Onset < 18 (%) | ||||
Not available | 9 (20.0) | 3 (23.1) | 0 (0.0) | n.s. |
No | 35 (77.8) | 8 (61.5) | 13 (100.0) | |
Yes | 1 (2.2) | 2 (15.4) | 0 (0.0) | |
Index Episode (%) | ||||
Depressive | 21 (46.7) | 10 (76.9) | 6 (46.2) | n.s. |
[Hypo]manic | 16 (35.6) | 0 (0.0) | 2 (15.4) | |
Not available | 8 (17.8) | 3 (23.1) | 5 (38.5) | |
Long-acting Injection (%) | ||||
No | 30 (66.7) | 11 (84.6) | 12 (92.3) | n.s. |
Yes | 15 (33.3) | 2 (15.4) | 1 (7.7) | |
Prevalent Polarity (%) | ||||
Depressive | 12 (26.7) | 11 (84.6) | 7 (53.8) | <0.001 |
Manic | 22 (48.9) | 0 (0.0) | 0 (0.0) | |
Mixed | 2 (4.4) | 2 (15.4) | 4 (30.8) | |
None | 9 (20.0) | 0 (0.0) | 2 (15.4) | |
No. Psych Admissions (median [IQR]) | 2.00 [1.00, 3.00] | 2.00 [1.00, 2.00] | 2.00 [1.00, 2.00] | n.s. |
No. Med Admissions (median [IQR]) | 0.00 [0.00, 1.00] | 0.00 [0.00, 0.00] | 0.00 [0.00, 0.00] | n.s. |
No. Psych Admissions (Total) | 45 | 13 | 13 | |
No. Med Admissions (Total) | 13 | 2 | 3 | |
No. deaths | ||||
Suicide | 0 | 0 | 1 | |
Other causes (unknown, lymphoma, COVID-19) | 4 | 0 | 0 |
BD-I, Bipolar Disorder Type I; BD-II, Bipolar Disorder Type II; BD-NOS, Bipolar Disorder – Not Otherwise Specified; IQR, interquartile range; n.s., not significant; SD, standard deviation.